Literature DB >> 18448676

High blood pressure arising from a defect in vascular function.

Simon K Michael1, Howard K Surks, Yuepeng Wang, Yan Zhu, Robert Blanton, Michelle Jamnongjit, Mark Aronovitz, Wendy Baur, Kenichi Ohtani, Michael K Wilkerson, Adrian D Bonev, Mark T Nelson, Richard H Karas, Michael E Mendelsohn.   

Abstract

Hypertension, a major cardiovascular risk factor and cause of mortality worldwide, is thought to arise from primary renal abnormalities. However, the etiology of most cases of hypertension remains unexplained. Vascular tone, an important determinant of blood pressure, is regulated by nitric oxide, which causes vascular relaxation by increasing intracellular cGMP and activating cGMP-dependent protein kinase I (PKGI). Here we show that mice with a selective mutation in the N-terminal protein interaction domain of PKGIalpha display inherited vascular smooth muscle cell abnormalities of contraction, abnormal relaxation of large and resistance blood vessels, and increased systemic blood pressure. Renal function studies and responses to changes in dietary sodium in the PKGIalpha mutant mice are normal. These data reveal that PKGIalpha is required for normal VSMC physiology and support the idea that high blood pressure can arise from a primary abnormality of vascular smooth muscle cell contractile regulation, suggesting a new approach to the diagnosis and therapy of hypertension and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448676      PMCID: PMC2373316          DOI: 10.1073/pnas.0802128105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II.

Authors:  A P Somlyo; A V Somlyo
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 2.  Molecular and cellular mechanisms regulating vascular function and structure--implications in the pathogenesis of hypertension.

Authors:  R M Touyz
Journal:  Can J Cardiol       Date:  2000-09       Impact factor: 5.223

Review 3.  The biology of cyclic GMP-dependent protein kinases.

Authors:  Franz Hofmann
Journal:  J Biol Chem       Date:  2004-11-15       Impact factor: 5.157

Review 4.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.

Authors:  Y Fukata; M Amano; K Kaibuchi
Journal:  Trends Pharmacol Sci       Date:  2001-01       Impact factor: 14.819

Review 5.  Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development.

Authors:  Ferid Murad
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

6.  M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells.

Authors:  Howard K Surks; Nadeene Riddick; Ken-Ichi Ohtani
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

7.  In hypertension, the kidney is not always the heart of the matter.

Authors:  Michael E Mendelsohn
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 8.  Elevated systolic blood pressure as a cardiovascular risk factor.

Authors:  W B Kannel
Journal:  Am J Cardiol       Date:  2000-01-15       Impact factor: 2.778

9.  Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.

Authors:  V Sauzeau; H Le Jeune; C Cario-Toumaniantz; A Smolenski; S M Lohmann; J Bertoglio; P Chardin; P Pacaud; G Loirand
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

10.  Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha.

Authors:  H K Surks; N Mochizuki; Y Kasai; S P Georgescu; K M Tang; M Ito; T M Lincoln; M E Mendelsohn
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

View more
  63 in total

1.  Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure prediction.

Authors:  Andriy Kryshtafovych; John Moult; Sergio G Bartual; J Fernando Bazan; Helen Berman; Darren E Casteel; Evangelos Christodoulou; John K Everett; Jens Hausmann; Tatjana Heidebrecht; Tanya Hills; Raymond Hui; John F Hunt; Jayaraman Seetharaman; Andrzej Joachimiak; Michael A Kennedy; Choel Kim; Andreas Lingel; Karolina Michalska; Gaetano T Montelione; José M Otero; Anastassis Perrakis; Juan C Pizarro; Mark J van Raaij; Theresa A Ramelot; Francois Rousseau; Liang Tong; Amy K Wernimont; Jasmine Young; Torsten Schwede
Journal:  Proteins       Date:  2011-10-21

2.  Renal actions of RGS2 control blood pressure.

Authors:  Susan B Gurley; Robert C Griffiths; Michael E Mendelsohn; Richard H Karas; Thomas M Coffman
Journal:  J Am Soc Nephrol       Date:  2010-09-16       Impact factor: 10.121

3.  A crystal structure of the cyclic GMP-dependent protein kinase I{beta} dimerization/docking domain reveals molecular details of isoform-specific anchoring.

Authors:  Darren E Casteel; Eric V Smith-Nguyen; Banumathi Sankaran; Sung H Roh; Renate B Pilz; Choel Kim
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

Review 4.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

5.  Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure.

Authors:  Yan-Ning Qiao; Wei-Qi He; Cai-Ping Chen; Cheng-Hai Zhang; Wei Zhao; Pei Wang; Lin Zhang; Yan-Ze Wu; Xiao Yang; Ya-Jing Peng; Ji-Min Gao; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2014-06-20       Impact factor: 5.157

6.  Mutation of the protein kinase I alpha leucine zipper domain produces hypertension and progressive left ventricular hypertrophy: a novel mouse model of age-dependent hypertensive heart disease.

Authors:  Robert M Blanton; Eiki Takimoto; Mark Aronovitz; Robrecht Thoonen; David A Kass; Richard H Karas; Michael E Mendelsohn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-08       Impact factor: 6.053

7.  Sacubitril/Valsartan Improves Left Ventricular Function in Chronic Pressure Overload Independent of Intact Cyclic Guanosine Monophosphate-dependent Protein Kinase I Alpha Signaling.

Authors:  Kelly Tam; Daniel A Richards; Mark J Aronovitz; Gregory L Martin; Suchita Pande; Iris Z Jaffe; Robert M Blanton
Journal:  J Card Fail       Date:  2020-05-25       Impact factor: 5.712

Review 8.  L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.

Authors:  Kevin S Heffernan; Christopher A Fahs; Sushant M Ranadive; Eshan A Patvardhan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2010-01-06       Impact factor: 2.457

9.  Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα.

Authors:  Mikio Kato; Robert Blanton; Guang-Rong Wang; Timothy J Judson; Yuich Abe; Masafumi Myoishi; Richard H Karas; Michael E Mendelsohn
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

10.  cGMP-dependent protein kinase I is crucial for angiogenesis and postnatal vasculogenesis.

Authors:  Alexandra Aicher; Christopher Heeschen; Susanne Feil; Franz Hofmann; Michael E Mendelsohn; Robert Feil; Stefanie Dimmeler
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.